Kevin P. Kennedy, MD

VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

  • 1Article
  • 990Reads
  • 2026Active
  • 6Collaborators

About

Kevin P. Kennedy, MD is affiliated with VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania. Kevin P. Kennedy has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2026. Their work focuses on Addiction, Metabolic Disorders, and Veterans and Military Issues.

Publications

JCP
GLP-1 Receptor Agonists and Overdose Risk in Veterans with Type 2 Diabetes and Opioid Use Disorder
Original Research

GLP-1 Receptor Agonists and Overdose Risk in Veterans with Type 2 Diabetes and Opioid Use Disorder

July 15, 2026

Semaglutide and tirzepatide were associated with lower risk of all-cause overdose compared to insulin and SGLT2i inhibitors, but not metformin, sulfonylureas, or DPP4 inhibitors.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe